# Normalization of Fasting Glucose and the Incidence of Restenosis After Peripheral Angioplasty

> **NCT01150617** · PHASE4 · TERMINATED · sponsor: **IRCCS San Raffaele** · enrollment: 46 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Peripheral Vascular Disease

## Interventions

- **DRUG:** Insulin glargine plus insulin analogues

## Key facts

- **NCT ID:** NCT01150617
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-12
- **Primary completion:** 2010-11
- **Final completion:** 2011-05
- **Target enrollment:** 46 (ACTUAL)
- **Why stopped:** end-point reached
- **Last updated:** 2012-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01150617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01150617, "Normalization of Fasting Glucose and the Incidence of Restenosis After Peripheral Angioplasty". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01150617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*